Heart of gold: researchers use gold spray to restore heart function in mouse modelInnovative spray-on technology could be used to repair heart following myocardial infarction. Long-term cardiovascular risks are substantial in COVID-19 survivors Survivors of COVID-19 are at increased risk of adverse cardiovascular outcomes even if they were not hospitalized during the acute phase of infection. Spironolactone not associated with a significant increase in cancer risk Systematic review and meta-analysis finds no substantial increased risk of cancer with spironolactone, and a decreased risk of prostate cancer. Sudden death in athletes reduced three-fold with bystander training Paris-based study shows training programs work—Canadian experts push for bystander education at a national level. No increased risk of congenital anomalies from statin use during pregnancy Taiwan study helps answer some safety questions. QUIZ: Test your dyslipidemia knowledge How much do you know about detecting and treating dyslipidemia for the prevention of cardiovascular disease? Study finds 15-fold increase in maternal deaths related to chronic hypertension Worrying trend seen over the past 40 years with chronic hypertension, older maternal age, obesity to blame. POP QUIZ: Meds that can worsen heart failure Which of the following medications is least likely to worsen heart failure with reduced ejection fraction (HFrEF)? Women with vascular issues at higher risk of cognitive decline than men Study finds greater declines in memory, language, and attention while men have decline in language scores. Guidance on titrating therapy for heart failure with reduced ejection fraction Goal is to titrate quadruple therapy to maximally tolerated doses within three to six months of diagnosis First Previous 21 22 23 24 25 Next Last
